Do you think a drug (such as Rems...) could have a high SI

New Post Public Reply Private Reply Replies (1) Message Board
petemantx farrell #65923
665
Do you think a drug (such as Rems...) could have a high SI and not prove a real blockbuster treatment in human testing, because to date that is what I feel has been the story regarding Rems....

When you have to change the endpoints of a trial and eliminate the mortality figures I personally question the entire trial.

I am probably in the distinct minority that believe Rems... is where it is at today thanks to lots of payola. But then it is what it is and we will see from the current trial if I am judging it far too harshly or not.

Whatever the results, I don't think they will prove justification for the cost of Rems.... treatment. Think B will prove much more effective and here we are hoping IPIX is able to reduce the treatment cost significantly for the sake of the world. Anybody think that has crossed the mind of Gilead execs, to try and lower the price of Rems... to help the world??

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Greenlight Networks Invests $100 Million to Boost Connectivity

Updated Category News Views 336

Greenlight Networks Expands Fiber Internet Services Greenlight Networks, a prominent fiber-to-the-home internet provider, is set to expand its fiber services into a new area with a significant investment of $100 million. This expansion aims to enhance high-speed internet access for residents and small businesses, ushering in new opportunities for economic growth and...

Continue Reading
Analyzing Meta Platforms in the Competitive Media Landscape

Updated Category News Views 152

Understanding Meta Platforms in the Market In the rapidly evolving business environment, it’s crucial for investors to closely examine firms prior to making investment choices. This article will provide a detailed analysis of Meta Platforms (NASDAQ: META) within the context of its main rivals in the Interactive Media & Services sector. By reviewing essential financial...

Continue Reading
Insights into Early Redemptions of Bonds Issued by Jyske Realkredit

Updated Category News Views 156

Exploring Preliminary Data on Early Redemptions In light of recent financial insights, Jyske Realkredit has released preliminary data regarding early redemptions, specifically focusing on prepayments related to bonds. This intriguing announcement is intended for stakeholders and interested parties looking to understand the dynamics of the bond market. Understanding Early...

Continue Reading
Eltek Ltd. Reports Robust Growth in Latest Financial Quarter

Updated Category News Views 64

Eltek Ltd. Announces Strong Performance for Q3 2024 Eltek Ltd. (NASDAQ: ELTK), a world-leading manufacturer of advanced printed circuit board solutions, has recently reported remarkable financial results for its third quarter, demonstrating a meaningful surge in revenues and profits. The company’s commitment to innovative practices in the PCB sector is reflected in its...

Continue Reading
Anticipation Grows for Palantir's AI Conference Insights

Updated Category News Views 132

Excitement Grows for Palantir Technologies' AI Conference As Palantir Technologies prepares for its upcoming conference focused on artificial intelligence, industry experts are eagerly anticipating the insights that could come from this significant event. A key topic of discussion is the recent extension of Palantir's partnership with a major energy player. Strategic...

Continue Reading